Arrowstreet Capital’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
26,999
-11,186
-29% -$433K ﹤0.01% 1626
2026
Q1
$1.44M Buy
38,185
+16,866
+79% +$551K ﹤0.01% 1473
2025
Q4
$641K Buy
+21,319
New +$603K ﹤0.01% 1647

Other funds holding GRDN

Arrowstreet Capital's GRDN Position: Q2 2026 in Review

Arrowstreet Capital reduced its Guardian Pharmacy Services (GRDN) stake by 29% in Q2 2026, selling an estimated $433K and leaving 26,999 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Arrowstreet Capital first reported a position in GRDN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Arrowstreet Capital held 26,999 shares of Guardian Pharmacy Services worth $1.13M as of Q2 2026.
  • Arrowstreet Capital sold 11,186 Guardian Pharmacy Services shares in Q2 2026, an estimated $433K.
  • Guardian Pharmacy Services made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1626 holding.
  • Arrowstreet Capital first reported a position in Guardian Pharmacy Services in Q4 2025 and has held it in 3 quarters since.
  • Arrowstreet Capital's Guardian Pharmacy Services position peaked at $1.44M in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.